The scientific world is actively discussing new methods of combating cancer diseases, which involves to fight the disease the immune system of the patient. In clinical trials in over half of the terminally ill blood cancer patients there is complete remission, reports The Guardian.
The experiment involved several dozen patients, according to doctors, still live not more than a few months.
During the tests of the immune system patients were withdrawn T-lymphocytes, which are responsible for the recognition and destruction of cells carrying foreign antigens. Scientists genetically modified T-lymphocytes so that they began to recognize and kill cells of acute lymphoblastic leukemia and other types of blood cancer.
As a result, 94% of patients suffering from acute lymphoblastic leukemia, lost all symptoms. Over 80% of patients with other types of blood cancer also responded positively to the treatment, and half it is observed complete remission.